Cargando…

Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada

Historically, overpolicing of some racialized and Indigenous groups in Canada has resulted in unequal application of drug laws contributing to disproportionate rates of charges and convictions in these populations. Criminal records severely and negatively impact an individual’s life and can perpetua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiese, Jessica L., Watson, Tara Marie, Owusu-Bempah, Akwasi, Hyshka, Elaine, Wells, Samantha, Robinson, Margaret, Elton-Marshall, Tara, Rueda, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885015/ https://www.ncbi.nlm.nih.gov/pubmed/36733492 http://dx.doi.org/10.1177/00914509221142156

Ejemplares similares

“Tea” time? Cannabis legalization in Canada
por: Sorge, Justin
Publicado: (2018)

Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada
por: Somé, Nibene H., et al.
Publicado: (2022)

Too young for Cannabis? Choice of minimum legal age for legalized non-medical Cannabis in Canada
por: Nguyen, Hai V., et al.
Publicado: (2020)

Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada
por: Myran, Daniel T., et al.
Publicado: (2022)

Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
por: Myran, Daniel T., et al.
Publicado: (2023)

Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances
por: Crépault, Jean-François
Publicado: (2018)

Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws
por: Martins, Silvia S., et al.
Publicado: (2021)

Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020
por: Imtiaz, Sameer, et al.
Publicado: (2022)

Association of Racial Disparity of Cannabis Possession Arrests Among Adults and Youths With Statewide Cannabis Decriminalization and Legalization
por: Sheehan, Brynn E., et al.
Publicado: (2021)

A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada
por: Asselin, Antoine, et al.
Publicado: (2022)

Changes in Youth Cannabis Use After an Increase in Cannabis Minimum Legal Age in Quebec, Canada
por: Nguyen, Hai V., et al.
Publicado: (2022)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Initial indicators of the public health impacts of non-medical cannabis legalization in Canada
por: Fischer, Benedikt, et al.
Publicado: (2020)

An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
por: Fischer, Benedikt, et al.
Publicado: (2021)

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014–2017 in Ontario, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review
por: Mehra, Kamna, et al.
Publicado: (2023)

Legal cannabis—what's in it?
por: Cousijn, Janna
Publicado: (2020)

Perceptions About Cannabis Following Legalization Among Pregnant Individuals With Prenatal Cannabis Use in California
por: Young-Wolff, Kelly C., et al.
Publicado: (2022)

Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
por: Wadsworth, Elle, et al.
Publicado: (2022)

Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
por: Myran, Daniel Thomas, et al.
Publicado: (2022)

Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada
por: Myran, Daniel T., et al.
Publicado: (2023)

Cannabis use patterns among patients with upper extremity conditions at the time of legalization in Canada
por: Sims, Laura, et al.
Publicado: (2022)

Youth cannabis use in Canada post-legalization: service providers’ perceptions, practices, and recommendations
por: Kourgiantakis, Toula, et al.
Publicado: (2023)

Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis
por: Somé, Nibene Habib, et al.
Publicado: (2022)

Increasing racially and ethnically underrepresented women in medical school through an innovative program
por: Geller, Pamela A., et al.
Publicado: (2017)

Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT)
por: Tosur, Mustafa, et al.
Publicado: (2023)

Adolescent exposure to cannabis marketing following recreational cannabis legalization in Canada: A pilot study using ecological momentary assessment
por: Noël, Chelsea, et al.
Publicado: (2021)

Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015–2020: a whole population retrospective cohort study
por: Butler, Amanda, et al.
Publicado: (2023)

“Where does the high road lead?” Potential implications of cannabis legalization for pediatric injuries in Canada
por: Karbakhsh, Mojgan, et al.
Publicado: (2018)

Beliefs about cannabis at the time of legalization in Canada: results from a general population survey
por: Cunningham, John A.
Publicado: (2020)

Correction to: Cannabis use patterns among patients with upper extremity conditions at the time of legalization in Canada
Publicado: (2022)

Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
por: Fischer, Benedikt, et al.
Publicado: (2023)

A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE
por: Iablokov, V, et al.
Publicado: (2023)

Seeking Inclusion Excellence: Understanding Racial Microaggressions as Experienced by Underrepresented Medical and Nursing Students
por: Ackerman-Barger, Kupiri, et al.
Publicado: (2020)

Anti‐racism structures in academic dentistry: Supporting underrepresented racially/ethnically diverse faculty
por: Smith, Sonya G., et al.
Publicado: (2022)

Consumer perceptions of legal cannabis products in Canada, 2019–2021: a repeat cross-sectional study
por: Wadsworth, Elle, et al.
Publicado: (2022)

Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada
por: Capler, N. Rielle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_37d8i912fcke2aqa1q05qi4p6i